MedTrace Logo

Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)

NCT02512653 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2016-06-20

No results posted yet for this study

Summary

Biological Standardization of Cupressus arizonica Allergen Extract.

Conditions

  • Allergy to Tree Pollen

Interventions

BIOLOGICAL

Cupressus arizonica

Four different concentrations of Cupressus arizonica allergen extract, positive control and negative control

Sponsors & Collaborators

  • Laboratorios Leti, S.L.

    lead INDUSTRY

Principal Investigators

  • Lena Erbiti · Laboratorios Leti, S.L.U

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02512653 on ClinicalTrials.gov